Kidney and urologic disease status update: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 596: Line 596:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
|-
|-
Line 605: Line 605:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Iqra
| style="padding: 5px 5px; background: #F5F5F5;" |Iqra
|-
|-
Line 614: Line 614:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
|-
|-
Line 622: Line 622:
| style="padding: 5px 5px; background: #F5F5F5;" |Sunny/ Seyd
| style="padding: 5px 5px; background: #F5F5F5;" |Sunny/ Seyd
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
|-
|-
Line 631: Line 631:
| style="padding: 5px 5px; background: #F5F5F5;" |rc Arash
| style="padding: 5px 5px; background: #F5F5F5;" |rc Arash
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
|-
|-
Line 640: Line 640:
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian  
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian  
|-
|-
Line 649: Line 649:
| style="padding: 5px 5px; background: #F5F5F5;" |Akshun
| style="padding: 5px 5px; background: #F5F5F5;" |Akshun
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
|-
|-
Line 658: Line 658:
| style="padding: 5px 5px; background: #F5F5F5;" |Shamila
| style="padding: 5px 5px; background: #F5F5F5;" |Shamila
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
|-
Line 745: Line 745:
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
|-
|-
Line 753: Line 753:
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
|-
|-
Line 761: Line 761:
| style="padding: 5px 5px; background: #F5F5F5;" |Khurram
| style="padding: 5px 5px; background: #F5F5F5;" |Khurram
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
|-
|-
Line 769: Line 769:
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
|-
Line 777: Line 777:
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Sadaf
| style="padding: 5px 5px; background: #F5F5F5;" |Sadaf
|-
|-
Line 785: Line 785:
| style="padding: 5px 5px; background: #F5F5F5;" |Manpreet
| style="padding: 5px 5px; background: #F5F5F5;" |Manpreet
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian
|-
|-
Line 793: Line 793:
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
| style="padding: 5px 5px; background: #F5F5F5;" |Anmol
|-
|-
Line 809: Line 809:
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun
|-
|-
Line 817: Line 817:
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Mehdi
| style="padding: 5px 5px; background: #F5F5F5;" |Mehdi
|-
|-
Line 825: Line 825:
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Yes
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |Done
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
| style="padding: 5px 5px; background: #F5F5F5;" |Farima
|-
|-
|}
|}

Revision as of 14:50, 8 July 2020

System leader: Maneesha Nandimandalam, MD

Progress
Completed 33
In progress 1
Remaining 30

List of Chapters Requiring Content

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases
  • Abderhalden-Kaufmann-Lignac syndrome
  • Analgesic nephropathy
 Assigned Shakiba Elsaiey, Ahmed
  • Balkan nephropathy
  • Continuous veno-venous hemofiltration
  • Contrast-induced acute kidney injury
  • Dent's disease
  • Dialysis (LP)
  • Diuresis
  • Fibrillary immunotactoid glomerulopathy
  • Glomerulosclerosis
  • Hypophosphatemia
  • Haff disease
  • Hemodialysis (SP)
  • HIV associated nephropathy
 Assigned Shakiba Elsaiey,Ahmed Completed
  • Hypertensive nephropathy
 Assigned Nasrin Elsaiey,Ahmed
  • Kidney transplantation
  • Milk-alkali syndrome
  • Multicystic dysplastic kidney
  • Nephroptosis
  • Nutcracker syndrome
  • Papillorenal syndrome
  • Peritoneal dialysis (SP)
  • Phosphate nephropathy
 Assingned Ayesha FJ Sogand
  • Pyonephrosis
  • Rhabdomyolysis
 Assingned Ayesha FJ, Sogand
  • Rebound diuresis
  • Renal agenesis
  • Renal artery stenosis
  • Renal papillary necrosis
  • Thin basement membrane disease

In progress chapters

Category Chapters that need content Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Cardiorenal syndrome Assigned Dina Huda

Completed chapters

Category Chapters Assignment Status Scholar's name Coach name Completion Status Review status Reviewer name
Kidney diseases Electrolyte imbalance (LP) Mehdi Yes Done Mehrian
Hyponatremia Saeedeh Yes Done Mahshid
Hypernatremia Feham Yes Done Elsaiey
Hypokalemia Rc-Aida Yes Done Mahshid
Hyperkalemia Jogeet Yes Done Amandeep
Hypocalcemia Krishna Yes Done Hasan
Hypercalcemia Anmol Yes Done Sudarshana Datta
Glomerular Disease(LP) Mehrian Yes Done Farima
Lupus Nephritis Aida/ Omer Yes Done Iqra
Rapidly progressive glomerulonephritis Nazia / Jogeet Yes Done Aditya
Membranous glomerulonephritis Sunny/ Seyd Yes Done Amandeep
Membranoproliferative glomerulonephritis rc Arash Yes Done Aditya
IgA nephropathy Dildar Yes Done Mehrian
Goodpasture syndrome Akshun Yes Done Farima
Amyloidosis (LP) Shamila Yes Done Mehrian
Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type(senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
Hydronephrosis Chandra Yes Done Aditya
Kidney stone Amandeep Yes Done Aditya
Polycystic kidney disease Khurram Yes Done Anmol
Nephritic syndrome Dildar Yes Done Mehrian
Nephrotic syndrome Mehrian Yes Done Sadaf
Post-streptococcal glomerulonephritis Manpreet Yes Done Mehrian
Renal cell carcinoma Farima Yes Done Anmol
Renal osteodystrophy
Renal tubular acidosis Aditya Yes Done Sargun
Renal vein thrombosis Saeedeh Yes Done Mehdi
Wilms' tumor Sargun Yes Done Farima
Retrieved from "https://www.wikidoc.org/index.php?title=Kidney_and_urologic_disease_status_update&oldid=1622788"